Superior efficacy shown in two head-to-head phase III trials, including overall survival in DREAMM-7  Blenrep combinations ...

Cell models are replacing animal testing in pharma. Explore expert tips on transitioning to more accurate, ethical and ...

University of Florida researchers said a new study could lead to a universal cancer shot, while digital health earnings ...

"Chronic hives are treated with antihistamines, usually second-generation antihistamines, which are less sedating and last ...

DelveInsight's Claudin 18.2 Directed Therapies Market Size, Target Population, Competitive Landscape & Market Forecast report ...

Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of HBM9378/WIN378 in patients with asthma, with an initial data readout expected in mid-2026 HBM9378/WIN378 has the potential to be ...

DelveInsight’s Advanced Ovarian Cancer pipeline report depicts a robust space with 50+ active players working to develop 50+ pipeline therapies for Advanced Ovarian Cancer treatment.

Ikena Oncology, Inc. (Nasdaq: IKNA) ('Ikena”) and Inmagene Biopharmaceuticals ('Inmagene”) today announced the appointment of ...

A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly ...

DelveInsight's Diabetes pipeline report depicts a robust space with 200+ active players working to develop 200+ pipeline ...

David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and b ...

Amir Fathi, MD, discusses one of the biggest nonfinancial barriers to bispecific therapies: the expertise required to safely ...